These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


417 related items for PubMed ID: 21911891

  • 21. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
    Yıldırım ME, Karakuş S, Kurtulgan HK, Kılıçgün H, Erşan S, Bakır S.
    Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
    [Abstract] [Full Text] [Related]

  • 22. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
    Funk M, Endler G, Exner M, Marculescu R, Endler L, Abrahamian H, Mauler H, Grimm A, Raith M, Mannhalter C, Prager R, Irsigler K, Wagner OF.
    Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
    [Abstract] [Full Text] [Related]

  • 23. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML, Gómez García E, Leebeek F, Brouwers GJ, Koudstaal P, Dippel D.
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [Abstract] [Full Text] [Related]

  • 24. The prevalence of 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in central serous chorioretinopathy and its association with plasma PAI-1 levels.
    Sogutlu Sari E, Yazici A, Eser B, Erol MK, Kilic A, Ermis SS, Koytak A, Akşit H, Yakut T.
    Cutan Ocul Toxicol; 2014 Dec; 33(4):270-4. PubMed ID: 24446892
    [Abstract] [Full Text] [Related]

  • 25. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels.
    Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M.
    Eur J Endocrinol; 2004 Jun; 150(6):793-8. PubMed ID: 15191349
    [Abstract] [Full Text] [Related]

  • 26. 4G/5G polymorphism modulates PAI-1 circulating levels in obese women.
    Fernandes KS, Sandrim VC.
    Mol Cell Biochem; 2012 May; 364(1-2):299-301. PubMed ID: 22258825
    [Abstract] [Full Text] [Related]

  • 27. Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G/5G polymorphism.
    Solá E, Vayá A, España F, Castelló R, Ramón LA, Hernández-Mijares A, Vicente V, Estellés A.
    Thromb Res; 2008 May; 122(3):320-7. PubMed ID: 18037477
    [Abstract] [Full Text] [Related]

  • 28. Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.
    Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.
    Int J Hematol; 1999 Jan; 69(1):43-7. PubMed ID: 10641442
    [Abstract] [Full Text] [Related]

  • 29. [Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
    Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.
    Pol Arch Med Wewn; 2005 Jan; 113(1):7-20. PubMed ID: 16130596
    [Abstract] [Full Text] [Related]

  • 30. Relationship between gene polymorphism of the PAI-1 promoter and myocardial infarction.
    Fu L, Jin H, Song K, Zhang C, Shen J, Huang Y.
    Chin Med J (Engl); 2001 Mar; 114(3):266-9. PubMed ID: 11780311
    [Abstract] [Full Text] [Related]

  • 31. Role of the tissue-type plasminogen activator -7351C > T and plasminogen activator inhibitor 1 4G/5G gene polymorphisms in central serous chorioretinopathy.
    Malle EM, Posch-Pertl L, Renner W, Pinter-Hausberger S, Singer C, Haas A, Wedrich A, Weger M.
    Ophthalmic Genet; 2018 Dec; 39(6):714-716. PubMed ID: 30442055
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K, Herbepin VG, Touraine R, Almawi WY, Mahjoub T.
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [Abstract] [Full Text] [Related]

  • 35. Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients.
    Ezzidi I, Mtiraoui N, Chaieb M, Kacem M, Mahjoub T, Almawi WY.
    Diabetes Metab; 2009 Jun; 35(3):214-9. PubMed ID: 19419896
    [Abstract] [Full Text] [Related]

  • 36. Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.
    Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Celentano E, Panico S, Di Minno G.
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2082-7. PubMed ID: 9351375
    [Abstract] [Full Text] [Related]

  • 37. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
    Xu F, Liu H, Sun Y.
    Ren Fail; 2016 Oct; 38(1):157-62. PubMed ID: 26616527
    [Abstract] [Full Text] [Related]

  • 38. Plasminogen activator inhibitor-I (PAI-I) polymorphisms in patients with obstructive sleep apnoea.
    Barceló A, Llompart E, Barbé F, Morlá M, Vila M, Agustí AG.
    Respir Med; 2002 Mar; 96(3):193-6. PubMed ID: 11908512
    [Abstract] [Full Text] [Related]

  • 39. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A, Shetty S, Ghosh K, Kulkarni B.
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [Abstract] [Full Text] [Related]

  • 40. A novel G/A and the 4G/5G polymorphism within the promoter of the plasminogen activator inhibitor-1 gene in patients with deep vein thrombosis.
    Grubic N, Stegnar M, Peternel P, Kaider A, Binder BR.
    Thromb Res; 1996 Dec 15; 84(6):431-43. PubMed ID: 8987164
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 21.